» Articles » PMID: 34392110

Reduction and Exhausted Features of T Lymphocytes Under Serological Changes, and Prognostic Factors in COVID-19 Progression

Abstract

Aims: Coronavirus disease 2019 (COVID-19) is a novel viral infection threatening worldwide health as currently there exists no effective treatment strategy and vaccination programs are not publicly available yet. T lymphocytes play an important role in antiviral defenses. However, T cell frequency and functionality may be affected during the disease.

Material And Methods: Total blood samples were collected from patients with mild and severe COVID-19, and the total lymphocyte number, as well as CD4+ and CD8 + T cells were assessed using flowcytometry. Besides, the expression of exhausted T cell markers was evaluated. The levels of proinflammatory cytokines were also investigated in the serum of all patients using enzyme-linked immunesorbent assay (ELISA). Finally, the obtained results were analyzed along with laboratory serological reports.

Results: COVID-19 patients showed lymphopenia and reduced CD4+ and CD8 + T cells, as well as high percentage of PD-1 expression by T cells, especially in severe cases. Serum secretion of TNF-α, IL-1β, and IL-2 receptor (IL-2R) were remarkably increased in patients with severe symptoms, as compared with healthy controls. Moreover, high levels of triglyceride (TG) and low density lipoprotein cholesterol (LDL-C), were correlated with the severity of the disease.

Conclusion: Reduced number and function of T cells were observed in COVID-19 patients, especially in severe patients. Meanwhile, the secretion of proinflammatory cytokines was increased as the disease developed. High level of serum IL-2R was also considered as a sign of lymphopenia. Additionally, hypercholesterolemia and hyperlipidemia could be important prognostic factors in determining the severity of the infection.

Citing Articles

Navigating SARS-CoV-2-related immunopathology in Crohn's disease: from molecular mechanisms to therapeutic challenges.

Chen C, Lin Y, Liu K, Huang C, Shih C, Lee Y Virol J. 2024; 21(1):288.

PMID: 39538233 PMC: 11562311. DOI: 10.1186/s12985-024-02529-1.


The severity assessment and nucleic acid turning-negative-time prediction in COVID-19 patients with COPD using a fused deep learning model.

Liu Y, Zhang W, Sun M, Liang X, Wang L, Zhao J BMC Pulm Med. 2024; 24(1):515.

PMID: 39402509 PMC: 11476205. DOI: 10.1186/s12890-024-03333-x.


Identification and evaluation of candidate COVID-19 critical genes and medicinal drugs related to plasma cells.

Liu Z, Petinrin O, Chen N, Toseef M, Liu F, Zhu Z BMC Infect Dis. 2024; 24(1):1099.

PMID: 39363208 PMC: 11451256. DOI: 10.1186/s12879-024-10000-3.


Evaluation of changes in exhausted T lymphocytes and miRNAs expression in the different trimesters of pregnancy in pregnant women.

Shekarchi A, Hosseini L, Kamrani A, Alipourfard I, Soltani-Zangbar M, Akbari M Mol Biol Rep. 2024; 51(1):442.

PMID: 38520563 DOI: 10.1007/s11033-024-09370-3.


Integrative single-cell analysis: dissecting CD8 + memory cell roles in LUAD and COVID-19 via eQTLs and Mendelian Randomization.

Wu J, Mao X, Liu X, Mao J, Yang X, Zhou X Hereditas. 2024; 161(1):7.

PMID: 38297377 PMC: 10829297. DOI: 10.1186/s41065-023-00307-7.


References
1.
Bhimraj A, Morgan R, Shumaker A, Lavergne V, Baden L, Cheng V . Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. Clin Infect Dis. 2020; . PMC: 7197612. DOI: 10.1093/cid/ciaa478. View

2.
Mehra M, Ruschitzka F . COVID-19 Illness and Heart Failure: A Missing Link?. JACC Heart Fail. 2020; 8(6):512-514. PMC: 7151428. DOI: 10.1016/j.jchf.2020.03.004. View

3.
Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M . CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med. 2009; 15(8):914-20. DOI: 10.1038/nm.1964. View

4.
Ma X, Bi E, Lu Y, Su P, Huang C, Liu L . Cholesterol Induces CD8 T Cell Exhaustion in the Tumor Microenvironment. Cell Metab. 2019; 30(1):143-156.e5. PMC: 7061417. DOI: 10.1016/j.cmet.2019.04.002. View

5.
Mescher M, Curtsinger J, Agarwal P, Casey K, Gerner M, Hammerbeck C . Signals required for programming effector and memory development by CD8+ T cells. Immunol Rev. 2006; 211:81-92. DOI: 10.1111/j.0105-2896.2006.00382.x. View